Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06566911 · ClinicalTrials.gov registry record
Voice Analysis for Monitoring Patients With Heart Failure
A clinical trial of Heart Failure, sponsored by Noah Labs.
- Recruiting
- Registry status
- 70
- Enrollment target
- 2
- Study locations
NCT06566911: Recruiting study of Heart Failure, sponsored by Noah Labs.
NCT06566911 is a study of Heart Failure that is actively recruiting participants, run by Noah Labs. The registered enrollment target is 70 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06566911, a study of Heart Failure, is actively recruiting participants, sponsored by Noah Labs.
- RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 2
- Study locations
Study Summary
This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.
Conditions Studied
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
Other
- Deutsches Herzzentrum der Charité - Berlin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-01-24 |
| Est. Completion | 2024-09 |
What NCT06566911 shows while recruiting
NCT06566911 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT06566911 reports a single indexed study location in Minnesota, Other.
Frequently Asked Questions
What is clinical trial NCT06566911 about?
NCT06566911 is a clinical study titled "Voice Analysis for Monitoring Patients With Heart Failure". This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical info...
What is the current status of trial NCT06566911?
This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2024-01-24. Estimated completion is 2024-09.
What conditions does trial NCT06566911 study?
This clinical trial studies the following conditions: Heart Failure.
Who is sponsoring clinical trial NCT06566911?
This trial is sponsored by Noah Labs, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06566911 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06566911's enrollment target sits among peer trials
70 246th of 397 higher than 151 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI